CSI Market
Sign In | Register

Shockwave Medical Inc (SWAV) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SWAV quarterly Cash Flow →
This cash flow overview for Shockwave Medical Inc spans from Dec 31 2019 to Dec 31 2023, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income147.28
Depreciation & amortization10.36
Amortization of Other Assets1.51
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.27
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-31.01
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation73.23
Income (Loss) from Equity Method Investments1.87
Gains (Losses) on Extinguishment of Debt0.71
Operating Lease Right Of Use Asset Amortization-
Operating Lease Right Of Use Asset Amortization Expense3.16
Increase Decrease In Operating Lease Liability-1.28
Income taxes14.76
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-41.54
Increase (Decrease) in Accounts Payable0.11
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities32.92
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-3.42
Other Working Capital-4.49
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-8.40
Discontinued operations0.00
Net Cash flow from Operating Activities196.05
Investing Activities
Capital Expenditures-30.60
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities246.75
Payments to Acquire Available-for-sale Securities, Debt-747.47
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-94.41
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-625.73
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings810.46
Long-term debt - repayments105.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock7.60
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-210.04
Issuance Of Common Stock With Initial Public Offering Net Of Issuance Costs Value-
Payments Of Deferred Offering Costs-
Repayments Of Term Loan-
Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan-
Payment For Assumed Warrant Liabilities-16.24
Purchases Of Capped Calls Related To Convertible Debt-96.38
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities600.40
Effect of exchange rate on cash flow0.80
Discontinued operations0.00
Free Cash Flow165.46
Total Cash Flow171.52
4 historic quarters locked

Sign in to unlock the full Shockwave Medical Inc cash flow history.

Sign In Create Free Account

About Shockwave Medical Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: February 26, 2024
  • Source: swav-20231231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001642545-24-000063

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document